Bosentan-based, treat-to-target therapy in patients with pulmonary arterial hypertension: results from the COMPASS-3 study

Bosentan-based, treat-to-target therapy in patients with pulmonary arterial hypertension: results from the COMPASS-3 study

The phase 4 COMPASS-3 study evaluated whether a singular endpoint produces clinically meaningful outcomes in patients with pulmonary arterial hypertension (PAH). The relationship between cardiac magnetic resonance imaging (cMRI)-derived parameters and right heart catheterization (RHC) measurements w...

Full description

Bibliographic Details
Main Authors: Raymond L. Benza, Amresh Raina, Himanshu Gupta, Srinivas Murali, Annie Burden, Michael S. Zastrow, Myung H. Park, Marc A. Simon
Format: Article
Language:English
Published: SAGE Publishing 2018-01-01
Series:Pulmonary Circulation
Online Access:https://doi.org/10.1177/2045893217741480

Internet

https://doi.org/10.1177/2045893217741480

Similar Items